Cabozantinib is a medication that targets specific proteins in cancer cells to help stop them from growing and spreading. It works by blocking signals that cancer cells use to grow and create new blood vessels.

Atezolizumab is an immunotherapy medication that helps the body’s immune system recognize and fight cancer cells. It works by blocking a protein that cancer cells use to hide from the immune system.

Abiraterone is a hormone therapy medication used to treat prostate cancer. It works by stopping the body from producing testosterone, which can fuel prostate cancer growth.

Enzalutamide is also a hormone therapy medication for prostate cancer. It blocks testosterone from connecting with prostate cancer cells, which helps slow down or stop cancer growth.

Apalutamide is a hormone therapy medication that treats prostate cancer by preventing testosterone from helping cancer cells grow and spread.

Darolutamide is a hormone therapy medication used in prostate cancer treatment. It works by blocking the effects of testosterone on cancer cells.

Metastatic Castration-Resistant Prostate Cancer – A form of advanced prostate cancer that continues to grow despite treatments that lower testosterone levels in the body. In this condition, cancer cells have adapted to survive and multiply even when testosterone levels are very low. The cancer spreads (metastasizes) beyond the prostate to other parts of the body, commonly to bones, lymph nodes, or other organs. The disease typically develops progressively from earlier stages of prostate cancer, showing resistance to hormone therapy. The condition can affect multiple areas of the body simultaneously, with cancer cells forming new tumors in distant locations.